Key result
BiVAD support linked to fatal non-aneurysmal subarachnoid hemorrhage despite therapeutic anticoagulation.
Why the study?
Subarachnoid haemorrhage is a rare but catastrophic complication in patients supported by biventricular assist devices, with complex haemostatic challenges that are not well characterized.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Biventricular assist devices can create a complex functional coagulopathy that may result in catastrophic non-aneurysmal subarachnoid haemorrhage, which standard laboratory tests fail to adequately reflect.
Subarachnoid haemorrhage (SAH) is a rare but catastrophic complication in patients supported by biventricular assist devices (BiVADs).While mechanical circulatory support (MCS) is a life-saving bridge to transplantation, it introduces complex haemostatic challenges.We report the case of a 32-year-old male with hypertrophic cardiomyopathy who developed cardiogenic shock.He was bridged from central veno-arterial extracorporeal membrane oxygenation (cVA-ECMO) to BiVAD support.His clinical course was complicated by suspected heparin-induced thrombocytopaenia (HIT), but further testing proved he was HIT negative.After weeks of haemodynamic stability and the commencement of physical rehabilitation for heart transplant listing, the patient suffered a sudden and profound neurological decline.Imaging revealed a diffuse, non-aneurysmal SAH occupying the basal cisterns.Neurosurgical intervention included placement of an external ventricular drain; however, he further declined, and support was withdrawn.This case highlights the challenging haemostatic landscape inherent to ventricular assist devices (VADs), where standard laboratory tests fail to reflect profound functional coagulopathy.Ultimately, this case serves as a critical reminder that BiVADs create a challenging haemostatic environment that demands more sophisticated solutions.
No takes yet. Share an insight, caveat, or question.
Christopher Youssef (2026) conducted a case report in Cardiogenic shock secondary to hypertrophic cardiomyopathy (n=1). Biventricular assist device (BiVAD) was evaluated on Development of non-aneurysmal subarachnoid haemorrhage. A 32-year-old male on a biventricular assist device suffered a fatal non-aneurysmal subarachnoid haemorrhage despite a stable aPTT ratio, underscoring complex functional coagulopathy associated with mechanical circulatory support.
Synapse has enriched 10 related papers. Consider them for comparative context: